by Ken Chiacchia | Jul 13, 2021 | Bridges, Science Highlights
A two-step method identifies known drugs likely to reduce chance of death from covid-19 Bridges helps identify meds for other conditions that associate with lower death rates in COVID-19 patients by Ken Chiacchia Both the ongoing treatment of COVID-19 and readiness...
by Ken Chiacchia | Mar 8, 2021 | Science Highlights
Spring/Summer 2021 Rapid ID of Potential Anti-COVID-19 Agents Powered by Bridges-AI AI Identifies More Than 20,000 Compounds with Possible Anti-Virus Activity, Thousands of Times Faster than Earlier Methods by Ken Chiacchia The COVID-19 pandemic has shown that speed...
by Ken Chiacchia | Nov 16, 2020 | Press release
17th Annual HPCwire Awards Presented to Leaders in the Global HPC Community Artificial intelligence (AI) studies spanning from the tiny to the huge—from small molecules for fighting the SARS-CoV-2 virus to the enormous forces between colliding neutron...
by Ken Chiacchia | Jun 10, 2020 | Press release
Anton 2 Simulates Coronavirus Binding to Human Cells A team at the University of Arkansas is using the unparalleled ability of the Anton 2 supercomputer to simulate molecular systems for microseconds or longer to better understand how the Coronavirus that causes...
by Ken Chiacchia | May 20, 2020 | Press release
Bridges-Powered Experimental Test for Coronavirus Reveals Viral Changes, Host Responses A new experimental test to identify the SARS-CoV-2 virus from genetic material is being developed by an international team led by Weill Cornell Medicine scientists. Their new...